UB Paderborn / Katalog / Suche / in CDI

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Clinical infectious diseases, 2008-01, Vol.46 (2), p.201-211

2008

Volltextzugriff (PDF)

Gender medicine and oncology: report and consensus of an ESMO workshop

Annals of oncology, 2019-12, Vol.30 (12), p.1914-1924

2019

Volltextzugriff (PDF)

Strategies for the development of tdm for targeted anticancer agents

Clinical therapeutics, 2013-08, Vol.35 (8), p.e113-e114

Buclin, T

2013

Volltextzugriff (PDF)

High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4360-4367

2010

Volltextzugriff (PDF)

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study

Scientific reports, 2024-06, Vol.14 (1), p.12872-12

2024

Volltextzugriff (PDF)

Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

Clinical pharmacology and therapeutics, 2004-01, Vol.75 (1), p.13-33

2004

Volltextzugriff (PDF)

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-11, Vol.1157, p.122160, Article 122160

2020

Volltextzugriff (PDF)

Pregnancy outcome following maternal exposure to statins: a multicentre prospective study

BJOG : an international journal of obstetrics and gynaecology, 2013-03, Vol.120 (4), p.463-471

2013

Volltextzugriff (PDF)

The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material

The bone & joint journal, 2017-11, Vol.99-B (11), p.1537

2017

Volltextzugriff (PDF)

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-04, Vol.1236, p.124039-124039, Article 124039

2024

Volltextzugriff (PDF)

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial

Cancer chemotherapy and pharmacology, 2014-12, Vol.74 (6), p.1307-1319

2014

Volltextzugriff (PDF)

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022-11, Vol.1211, p.123456-123456, Article 123456

2022

Volltextzugriff (PDF)

Corrigendum to “Validation and clinical application of a multiplex high performance liquid chromatography – Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections” [J. Chromatogr. B 1157 (2020) 122160]

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022-11, Vol.1211, p.123497-123497, Article 123497

2022

Volltextzugriff (PDF)

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Clinical pharmacology and therapeutics, 2009-05, Vol.85 (5), p.485-494

2009

Volltextzugriff (PDF)

Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management

Current opinion in neurology, 2013-10, Vol.26 (5), p.481-488

2013

Volltextzugriff (PDF)

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-04, Vol.877 (11), p.1057-1069

2009

Volltextzugriff (PDF)

Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein

British journal of clinical pharmacology, 2006-07, Vol.62 (1), p.97-112

2006

Volltextzugriff (PDF)

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

AIDS (London), 2001-06, Vol.15 (9), p.1193-1194

2001

Volltextzugriff (PDF)

Prevalence and determinants of QT interval prolongation in medical inpatients

Internal medicine journal, 2012-08, Vol.42 (8), p.933-940

2012

Volltextzugriff (PDF)

Use of antiepileptic drugs during breastfeeding : What do we tell the mother?

Nervenarzt, 2018-08, Vol.89 (8), p.913-921

2018

Volltextzugriff (PDF)

Reassessment of Recommended Imipenem Doses in Febrile Neutropenic Patients with Hematological Malignancies

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.785-787

2009

Volltextzugriff (PDF)

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-05, Vol.819 (2), p.259-276

2005

Volltextzugriff (PDF)

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

British journal of cancer, 2008-05, Vol.98 (10), p.1633-1640

2008

Volltextzugriff (PDF)

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

British journal of clinical pharmacology, 2006-07, Vol.62 (1), p.97

2006

Volltextzugriff (PDF)

Serotonin, Melatonin and Their Metabolites Measured in Plasma by a New LC-MS/MS Assay In Healthy Volunteers

Clinical therapeutics, 2017-08, Vol.39 (8), p.e40-e41

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Gender medicine and oncology: report and consensus of an ESMO workshop

Strategies for the development of tdm for targeted anticancer agents

High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study

Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections

Pregnancy outcome following maternal exposure to statins: a multicentre prospective study

The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis

Corrigendum to “Validation and clinical application of a multiplex high performance liquid chromatography – Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections” [J. Chromatogr. B 1157 (2020) 122160]

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Prevalence and determinants of QT interval prolongation in medical inpatients

Use of antiepileptic drugs during breastfeeding : What do we tell the mother?

Reassessment of Recommended Imipenem Doses in Febrile Neutropenic Patients with Hematological Malignancies

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

Serotonin, Melatonin and Their Metabolites Measured in Plasma by a New LC-MS/MS Assay In Healthy Volunteers

Suchergebnisse filtern